While losing weight can improve body image and self-confidence, leading to a more satisfying sex life, some researchers question whether GLP-1 agonists may reduce sexual interest due to their effects on brain chemistry, particularly serotonin pathways
1 In the REIMAGINE 2 trial, the most commonly reported AEs were GI-related, occurring in 405/603 (67.2%) participants in the CagriSema 2.4 mg/2.4 mg group, 326/605 (53.9%) participants in the semaglutide 2.4 mg group, 60/152 (39.5%) participants in the cagrilintide 2.4 mg group, 329/594 (55.4%) participants in the CagriSema 1 mg/1 mg group, 288/608 (47.4%) participants in the semaglutide 1 mg group, and 42/149 (28.2%) participants in the placebo group
La actividad fsica mejora la sensibilidad a la insulina, complementando as la accin de GLP-1 en el control de la glucemia
Let's work together to understand your weight-loss needs so you can make the meaningful changes you need to get healthy and shed weight for good
The GLP-1R/GIPR/GcgR triple-agonist retatrutide achieves body weight loss (~25%) in just two-thirds of the time, potentially surpassing the efficacy of Roux-en-Y gastric bypass [29]
)
